Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review
October 2019
55
About the Report
About the Report
Elekta AB (EKTA B)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Elekta AB (Elekta) is a medical technology company that offers image guided clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.
Elekta AB Key Recent Developments
Aug 22,2019: Elekta: Interim report, May-July 2019/20
Jun 13,2019: Elekta increases focus on digitization-hires Sukhveer Singh to drive Elekta digital strategy
May 29,2019: Elekta: Year-end report May-April 2018/19
Mar 28,2019: ATOMEXPO 2019 to feature discussion on the possibilities of nuclear medicine around the World
Feb 22,2019: Elekta: Interim report May-January 2018/19
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Elekta AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Varian Medical Systems Inc
Siemens Healthineers AG
Revenio Group Oyj
Raysearch Laboratories AB
Philips Healthcare
BEBIG GmbH
Accuray Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Elekta AB-Key Facts
Elekta AB-Key Employees
Elekta AB-Key Employee Biographies
Elekta AB-Major Products and Services
Elekta AB-History
Elekta AB-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Elekta AB-Business Description
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: North and South America
Performance
R&D Overview
Elekta AB-SWOT Analysis
SWOT Analysis-Overview
Elekta AB-Strengths
Elekta AB-Weaknesses
Elekta AB-Opportunities
Elekta AB-Threats
Elekta AB-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Elekta AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Elekta AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Elekta AB, Recent Deals Summary
Section 5-Company's Recent Developments
Aug 22, 2019: Elekta: Interim report, May-July 2019/20
Jun 13, 2019: Elekta increases focus on digitization-hires Sukhveer Singh to drive Elekta digital strategy
May 29, 2019: Elekta: Year-end report May-April 2018/19
Mar 28, 2019: ATOMEXPO 2019 to feature discussion on the possibilities of nuclear medicine around the World
Feb 22, 2019: Elekta: Interim report May-January 2018/19
Nov 29, 2018: Elekta: Interim report May-October 2018/19 Q2
Sep 05, 2018: Elekta celebrates inauguration of new global radiotherapy innovation center
Aug 30, 2018: Elekta: Interim report May-July 2018/19
Jul 25, 2018: Elekta Implements PTC's ThingWorx on Microsoft Azure for Next Generation Remote Service
Jul 13, 2018: Elekta to donate advanced radiation therapy machine to Jordan's Al Bashir Hospital
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Elekta AB, Performance Chart (2015-2019)
Elekta AB, Ratio Charts
Elekta AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Elekta AB, Medical Equipment, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Elekta AB, Key Facts
Elekta AB, Key Employees
Elekta AB, Key Employee Biographies
Elekta AB, Major Products and Services
Elekta AB, History
Elekta AB, Other Locations
Elekta AB, Subsidiaries
Elekta AB, Key Competitors
Elekta AB, Ratios based on current share price
Elekta AB, Annual Ratios
Elekta AB, Annual Ratios (Cont...1)
Elekta AB, Annual Ratios (Cont...2)
Elekta AB, Interim Ratios
Elekta AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Elekta AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Elekta AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.